Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

456
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
456
Dementia01:30

Dementia

110
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
110
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

172
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
172

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Introducing the SAGE study: a multimodal protocol for testing a GABAergic mechanism of age-related episodic memory impairment across the sexes.

BMJ neurology open·2026
Same author

Context Memory Discrimination and Recognition in Humans: Development of a Novel Cognitive Task.

JMIR formative research·2026
Same author

In Response to Meniere's Disease and Migraine: Effect of Migraine Medications on Symptoms of Meniere's Disease.

The Laryngoscope·2026
Same author

Shorter Wound-healing Times Associated With Select Perioperative Medical Therapies in Hidradenitis Suppurativa Surgery, and a Limited Clinical Role of Intraoperative Cultures: A 194-Case Retrospective Review.

Annals of plastic surgery·2026
Same author

A plasma protein signature for cerebral amyloid angiopathy.

Acta neuropathologica·2026
Same author

Meniere's Disease and Migraine: Effect of Migraine Medications on Symptoms of Meniere's Disease.

The Laryngoscope·2026

相关实验视频

Updated: Jun 19, 2025

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.0K

使用数据融合与深度监督编码器进行阿尔茨海默病检测.

Minh Trinh1, Ryan Shahbaba2, Craig Stark3,4

  • 1Department of Computer Science, University of California, Los Angeles, Los Angeles, CA, United States.

Frontiers in dementia
|July 26, 2024
PubMed
概括

这项研究通过融合多种数据类型来增强阿尔茨海默病诊断. 一种具有中间数据融合的新监督编码方法显著提高了计算诊断的准确性.

关键词:
阿尔茨海默病的生物标志物阿尔茨海默氏症是阿尔茨海默氏症的一种疾病.数据整合数据集成.诊断 预测 诊断 预测减少维度,减少维度.多式联络融合多式联络融合多视图数据集成数据集成

更多相关视频

Author Spotlight: Enhancement of Salient Object Detection for Smart Grid Applications
03:31

Author Spotlight: Enhancement of Salient Object Detection for Smart Grid Applications

Published on: December 15, 2023

515
Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451
05:17

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451

Published on: April 18, 2025

124

相关实验视频

Last Updated: Jun 19, 2025

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.0K
Author Spotlight: Enhancement of Salient Object Detection for Smart Grid Applications
03:31

Author Spotlight: Enhancement of Salient Object Detection for Smart Grid Applications

Published on: December 15, 2023

515
Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451
05:17

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451

Published on: April 18, 2025

124

科学领域:

  • 计算神经科学是一种计算神经科学.
  • 医疗信息学医学信息学
  • 机器学习是机器学习.

背景情况:

  • 阿尔茨海默病 (AD) 诊断需要提高准确性和早期检测方法.
  • 当前的计算诊断通常依赖于单个数据模式,可能缺少关键信息.
  • 整合多种数据源 (多模式数据) 可能为诊断提供更全面的患者个人资料.

研究的目的:

  • 开发一个最佳的数据分析策略,以提高阿尔茨海默病的计算诊断.
  • 调查数据融合和缩小维度技术对诊断准确性的影响.
  • 为了比较各种融合策略 (简单,早期,中间) 和缩小维度的方法.

主要方法:

  • 进行了对80多种统计机器学习方法的全面比较.
  • 探索了三种数据融合策略:简单的连接,早期的融合 (连接然后减少维度) 和中间的融合 (减少维度然后连接).
  • 评估了常见的维度减小技术 (PCA,AE,LASSO) 和一种新的监督编码器 (SE).

主要成果:

  • 与PCA,AE和LASSO相比,监督编码器 (SE) 在预测准确度方面取得了显著的改进.
  • 当与SE结合时,中间数据融合为多类诊断预测提供了最高的准确性.
  • 多模式数据集成,加上有效的维度减小,增强了计算诊断能力.

结论:

  • 最佳的数据融合和维度减少策略对于精确的阿尔茨海默病计算诊断至关重要.
  • 监督编码器 (SE) 显示出作为多模 AD 数据的维度减小技术的显著前景.
  • 这项研究为开发更有效的AI驱动的神经退行性疾病诊断工具提供了框架.